Contract Pharma

Cellares, Stanford University Partner to Expand Automated Manufacturing Beyond T Cell Therapies

Cellares has joined forces with the Stanford Center for Definitive and Curative Medicine (CDCM) and Stanford Innovative ...
PharmiWeb

CDR-Life Appoints Dimitrios Chondros, MD, as Chief Medical Officer

Veteran biopharmaceutical executive brings global oncology and clinical development leadership to advance CDR-Life’s M-gager® platformZURICH--(BUSINESS WIRE)--CDR-Life, Inc., a clinical-stage ...
Fierce Biotech

FDA signals tailored approach to ‘carefully shepherd’ CAR-T therapy for autoimmune diseases

While interested in CAR-T therapies’ potential to achieve durable, drug-free remission in serious autoimmune conditions, the ...

Zelluna promotes Emilie Gauthy to Chief Technology Officer

Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell ...

WuXi Biologics and Vertex Sign License and Research Service Agreement for T-cell Engager

WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service agreement with ...
Hosted on MSN

Normunity raises $75m to advance solid tumour targeting T-cell engagers

US-based Normunity has raised $75m in a Series B funding round to support the clinical development of its lead programme, NRM-823, a potential first-in-class T-cell engager (TCE) targeting solid ...